Press Release: Strategic Alliance

SMH Automation Ltd & Medica Pharming BV Launch Global Turnkey Projects Enterprise (GTPE) Holdings

The Strategic Alliance Delivers End-to-End Pharmaceutical Solutions Worldwide

In a landmark partnership reshaping the pharmaceutical project landscape, Medica Pharming BV and SMH Automation have jointly launched Global Turnkey Projects Enterprise Holding (GTPEH); A game-changing platform offering fully integrated, turnkey solutions for pharmaceutical investment and operations across Europe, MENA, Asia, and North America.

GTPEH combines the core strengths of:
– Medica Pharming BV: Experts in pharmaceutical quality assurance, compliance, and drug development.
– SMH Automation: Leaders in advanced digitisation technologies and process engineering.

What GTPEH Delivers?

Full oversight of management and consultation services for:

– Facility cGMP Design & Construction (Greenfield/Brownfield).
– IT/OT Strategy & Implementation.

– Business Automation Systems Integration (e.g. AI, IT and MRP/ERP, SAS).

– Process Automation Systems Integration (e.g. DCS, MES, SCADA, and LIMS).
– GxP-Compliant Equipment and Process Validation (cGMP, ISPE GAMP 5).
– Biosimilar & Drug Product Development.
– Clinical Batch Manufacturing & Tech Transfer.
– Digitalization, System Security & Data Integrity Solutions.

Why GTPEH?

GTPEH addresses the following key industry needs:
– Accelerated timelines
– Regulatory compliance certainty
– Global supply chain resilience
– Sustainable operational models

Executive Insights:


“GTPEH was born from a shared vision: to eliminate fragmentation in pharma projects by offering a true one-stop solution from concept to commercialization” — Reza Mohammadi, CEO, Medica Pharming BV

“This isn’t just a joint venture, but rather a next-generation delivery model. Our clients can now expect smarter, faster, and fully compliant execution across the Globe” — Saied Movahedi, CEO, SMH Automation

For Partnerships & Press Inquiries visit:

🌐 www.gtpeh.com

Latest News and Events

The pharmaceutical Contract Development Manufacturing Organisation (CDMO) market in Middle East & Africa is expected to reach a projected revenue of US$ 9,029.5 million by 2030. A compound annual growth rate of 5.2% is expected of Middle East & Africa pharmaceutical CDMO market from 2024 to 2030.